skip to main content

PVL Staphylococcal Pneumonia — SCE Infectious Diseases MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory InfectionPVL Staphylococcal PneumoniaSCE Infectious Diseases

A previously well adult develops rapidly progressive necrotising pneumonia after influenza; PVL-positive Staphylococcus aureus is identified. Which addition targets toxin production?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CAdd a protein-synthesis inhibitor such as clindamycin or linezolid alongside active anti-staphylococcal therapy with review after review with follow-up

The best answer is “Add a protein-synthesis inhibitor such as clindamycin or linezolid alongside active anti-staphylococcal therapy with review after review with follow-up”. Protein-synthesis inhibition can suppress exotoxin production, while definitive therapy must still cover the organism and provide organ support. “Continue a beta-lactam alone because PVL has no therapeutic relevance” is less appropriate because it conflicts with the decisive clinical feature or cited guidance. “Add gentamicin solely for toxin suppression” is less appropriate because it conflicts with the decisive clinical feature or cited guidance. “Use rifampicin monotherapy” is less appropriate because it conflicts with the decisive clinical feature or cited guidance. “Stop antibacterial therapy and give corticosteroid alone” is less appropriate because it conflicts with the decisive clinical feature or cited guidance.

Reference: UKHSA PVL-producing Staphylococcus aureus guidance: https://www.gov.uk/government/publications/pvl-staphylococcus-aureus-infections-diagnosis-and-management